BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 30022109)

  • 1. U6 can be used as a housekeeping gene for urinary sediment miRNA studies of IgA nephropathy.
    Duan ZY; Cai GY; Li JJ; Bu R; Wang N; Yin P; Chen XM
    Sci Rep; 2018 Jul; 8(1):10875. PubMed ID: 30022109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selection of urinary sediment miRNAs as specific biomarkers of IgA nephropathy.
    Duan ZY; Cai GY; Bu R; Lu Y; Hou K; Chen XM
    Sci Rep; 2016 Mar; 6():23498. PubMed ID: 27000966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of microRNAs in the urinary sediment of patients with IgA nephropathy.
    Wang G; Kwan BC; Lai FM; Chow KM; Kam-Tao Li P; Szeto CC
    Dis Markers; 2010; 28(2):79-86. PubMed ID: 20364043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel biomarkers in glomerular disease.
    Caliskan Y; Kiryluk K
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):205-16. PubMed ID: 24602470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary miRNA profile for the diagnosis of IgA nephropathy.
    Szeto CC; Wang G; Ng JK; Kwan BC; Mac-Moune Lai F; Chow KM; Luk CC; Lai KB; Li PK
    BMC Nephrol; 2019 Mar; 20(1):77. PubMed ID: 30832601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNAs in IgA nephropathy.
    Szeto CC; Li PK
    Nat Rev Nephrol; 2014 May; 10(5):249-56. PubMed ID: 24709842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of urinary exosomal microRNAs in IgA nephropathy.
    Min QH; Chen XM; Zou YQ; Zhang J; Li J; Wang Y; Li SQ; Gao QF; Sun F; Liu J; Xu YM; Lin J; Huang LF; Huang B; Wang XZ
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28383146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LG3 fragment of endorepellin is a possible biomarker of severity in IgA nephropathy.
    Surin B; Sachon E; Rougier JP; Steverlynck C; Garreau C; Lelongt B; Ronco P; Piedagnel R
    Proteomics; 2013 Jan; 13(1):142-52. PubMed ID: 23161552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary sediment miRNAs reflect tubulointerstitial damage and therapeutic response in IgA nephropathy.
    Liang S; Cai GY; Duan ZY; Liu SW; Wu J; Lv Y; Hou K; Li ZX; Zhang XG; Chen XM
    BMC Nephrol; 2017 Feb; 18(1):63. PubMed ID: 28201996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of the uteroglobin gene in systemic lupus erythematosus and IgA nephropathy.
    Menegatti E; Nardacchione A; Alpa M; Agnes C; Rossi D; Chiara M; Modena V; Sena LM; Roccatello D
    Lab Invest; 2002 May; 82(5):543-6. PubMed ID: 12003994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary mi-106a for the diagnosis of IgA nephropathy: Liquid biopsy for kidney disease.
    Szeto CC; Ng JK; Fung WW; Chan GC; Luk CC; Lai KB; Wang G; Chow KM; Mac-Moune Lai F
    Clin Chim Acta; 2022 May; 530():81-86. PubMed ID: 35278407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary Erythrocyte-Derived miRNAs: Emerging Role in IgA Nephropathy.
    Duan ZY; Cai GY; Li JJ; Bu R; Chen XM
    Kidney Blood Press Res; 2017; 42(4):738-748. PubMed ID: 29050002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of beta3 integrin gene Leu/Pro33 polymorphism on primary glomerulonephritis.
    Bantis C; Heering PJ; Aker S; Kuhr N; Grabensee B; Ivens K
    Nephron Exp Nephrol; 2005; 99(2):e33-7. PubMed ID: 15627799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Urinary miR-152-5p in Patients with IgA Nephropathy with Elevated Proteinuria Levels.
    Duan A; Liu L; Lou Y; Zhang D; Li H; Chen Y; Cui W; Miao L
    Clin Lab; 2019 Jul; 65(7):. PubMed ID: 31307184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
    Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
    BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary miR-16-5p can be used as a potential marker of endocapillary hypercellularity in IgA nephropathy.
    Zhang M; Duan ZY; Zhang QY; Xu XG; Zhang Y; Wang P; Duan SW; Wu J; Chen XM; Cai GY
    Sci Rep; 2023 Apr; 13(1):6048. PubMed ID: 37055445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of nuclear factor-kappaB in IgA nephropathy using Southwestern histochemistry.
    Ashizawa M; Miyazaki M; Abe K; Furusu A; Isomoto H; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
    Am J Kidney Dis; 2003 Jul; 42(1):76-86. PubMed ID: 12830459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary exosomal miRNA signature of IgA nephropathy: a case-control study.
    Shankar M; Shetty A; N S M; C G S; A K; Tennankore K
    Sci Rep; 2023 Dec; 13(1):21400. PubMed ID: 38049447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular profiling in IgA nephropathy and focal and segmental glomerulosclerosis.
    Tycová I; Hrubá P; Maixnerová D; Girmanová E; Mrázová P; Straňavová L; Zachoval R; Merta M; Slatinská J; Kollár M; Honsová E; Tesař V; Viklický O
    Physiol Res; 2018 Mar; 67(1):93-105. PubMed ID: 29137483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating and urinary microRNA profile in focal segmental glomerulosclerosis: a pilot study.
    Ramezani A; Devaney JM; Cohen S; Wing MR; Scott R; Knoblach S; Singhal R; Howard L; Kopp JB; Raj DS
    Eur J Clin Invest; 2015 Apr; 45(4):394-404. PubMed ID: 25682967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.